INTS Stock Analysis: Buy, Sell, or Hold?
INTS - Intensity Therapeutics, Inc. Common stock
$5.22
-0.08 (-1.60%)
▼
5d:
-4.49%
30d:
-17.61%
90d:
+1177.25%
BUY
HIGH Confidence
Analysis Updated: Apr 20, 2026 12:00 AM ET
Earnings: May 12, 2026
20d
Get Alerted When INTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INTS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: INTS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: INTS is currently trading at $5.21, which is considered oversold relative to its 30-day fair value range of $5.37 to $6.27.
Technical Outlook: Technically, INTS is in a strong uptrend. Immediate support is located at $5.00, while resistance sits at $5.75.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.50 (+695.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INTS is in a strong uptrend. Immediate support is located at $5.00, while resistance sits at $5.75.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.50 (+695.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.37 -
$6.27
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 695.8% below Wall St target ($41.50)
Fair Price Analysis
30-Day Fair Range
$5.37 -
$6.27
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.00
Resistance Level
$5.75
Current Trend
Strong Uptrend
Technical data as of
Apr 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.77
Wall Street Target
$41.50
(+695.8%)
Share & Embed Analysis
Last updated: April 21, 2026 5:16 AM ET
Data refreshes hourly during market hours. Next update: 6:16 AM
Data refreshes hourly during market hours. Next update: 6:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 59 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 61 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
